Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2019

Ausgabe 1/2019

Inhaltsverzeichnis ( 26 Artikel )

31.05.2019 | Editorial | Ausgabe 1/2019

Is sentinel node biopsy necessary in the radiologically negative axilla in breast cancer?

Felix Jozsa, Muneer Ahmed, Rose Baker, Michael Douek

24.05.2019 | Review | Ausgabe 1/2019

Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis

Bei Dong, Congyan Xie, Xiuchen Jing, Lu Lin, Li Tian

27.05.2019 | Review | Ausgabe 1/2019

Prognostic role of immune infiltrates in breast ductal carcinoma in situ

Xiao-Yang Chen, Joe Yeong, Aye Aye Thike, Boon Huat Bay, Puay Hoon Tan

22.05.2019 | Preclinical study | Ausgabe 1/2019

Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists

Erik Hedrick, Xi Li, Yating Cheng, Alexandra Lacey, Kumaravel Mohankumar, Mahsa Zarei, Stephen Safe

22.05.2019 | Preclinical study | Ausgabe 1/2019 Open Access

Breast cancer outcome prediction with tumour tissue images and machine learning

Riku Turkki, Dmitrii Byckhov, Mikael Lundin, Jorma Isola, Stig Nordling, Panu E. Kovanen, Clare Verrill, Karl von Smitten, Heikki Joensuu, Johan Lundin, Nina Linder

24.05.2019 | Preclinical study | Ausgabe 1/2019

Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study

Marta Pineda-Moncusí, Sonia Servitja, Ignasi Tusquets, Adolfo Diez-Perez, Albora Rial, Maria Lourdes Cos, Isabel Campodarve, Jaime Rodriguez-Morera, Natalia Garcia-Giralt, Xavier Nogués

29.05.2019 | Preclinical study | Ausgabe 1/2019

Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy

Melissa Krystel-Whittemore, Jin Xu, Edi Brogi, Katia Ventura, Sujata Patil, Dara S. Ross, Chau Dang, Mark Robson, Larry Norton, Monica Morrow, Hannah Y. Wen

01.06.2019 | Preclinical study | Ausgabe 1/2019

The impact of distinct triple-negative breast cancer subtypes on misdiagnosis and diagnostic delay

C. Elfgen, Z. Varga, K. Reeve, L. Moskovszky, V. Bjelic-Radisic, C. Tausch, U. Güth

04.06.2019 | Preclinical study | Ausgabe 1/2019

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome

Cody Plasterer, Shirng-Wern Tsaih, Amy R. Peck, Inna Chervoneva, Caitlin O’Meara, Yunguang Sun, Angela Lemke, Dana Murphy, Jennifer Smith, Sophia Ran, Albert J. Kovatich, Jeffrey A. Hooke, Craig D. Shriver, Hai Hu, Edith P. Mitchell, Carmen Bergom, Amit Joshi, Paul Auer, Jeremy Prokop, Hallgeir Rui, Michael J. Flister

24.05.2019 | Clinical trial | Ausgabe 1/2019

Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)

Bassam Basulaiman, Arif Ali Awan, Dean Fergusson, Lisa Vandermeer, Angel Arnaout, John Hilton, Brian Hutton, Anil Abraham Joy, Andrew Robinson, Nadia Califaretti, Carol Stober, Marta Sienkiewicz, Kednapa Thavorn, Mark Clemons

27.05.2019 | Clinical trial | Ausgabe 1/2019

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial

Matteo Lambertini, Christine Campbell, Richard D. Gelber, Giuseppe Viale, Ann McCullough, Florentine Hilbers, Larissa A. Korde, Olena Werner, Saranya Chumsri, Christian Jackisch, Antonio C. Wolff, Ines Vaz-Luis, Arlindo R. Ferreira, Aleix Prat, Alvaro Moreno-Aspitia, Martine Piccart, Sherene Loi, Evandro de Azambuja

31.05.2019 | Clinical trial | Ausgabe 1/2019

Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study

Manuel Ruíz-Borrego, Angel Guerrero-Zotano, Begoña Bermejo, Manuel Ramos, Josefina Cruz, Jose Manuel Baena-Cañada, Beatriz Cirauqui, Álvaro Rodríguez-Lescure, Emilio Alba, Noelia Martínez-Jáñez, Montserrat Muñoz, Silvia Antolín, Isabel Álvarez, Sonia Del Barco, Elena Sevillano, José Ignacio Chacón, Antonio Antón, María José Escudero, Victoria Ruiz, Eva Carrasco, Miguel Martín, GEICAM

04.06.2019 | Clinical trial | Ausgabe 1/2019

Sharing in care: engaging care partners in the care and communication of breast cancer patients

Jennifer L. Wolff, Jennifer Aufill, Diane Echavarria, JaAlah-Ai Heughan, Kimberley T. Lee, Roisin M. Connolly, John H. Fetting, Danijela Jelovac, Katie Papathakis, Carol Riley, Vered Stearns, Elissa Thorner, Nelli Zafman, Howard P. Levy, Sydney M. Dy, Antonio C. Wolff

22.05.2019 | Epidemiology | Ausgabe 1/2019

Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?

Maria K. Pomponio, Luke J. Keele, Kevin R. Fox, Amy S. Clark, Jennifer M. Matro, Lawrence N. Shulman, Julia C. Tchou

22.05.2019 | Epidemiology | Ausgabe 1/2019

Assessment of PARP4 as a candidate breast cancer susceptibility gene

Aldo Prawira, Prabhakaran Munusamy, Jimin Yuan, Claire Hian Tzer Chan, Geok Ling Koh, Timothy Wai Ho Shuen, Jiancheng Hu, Yoon Sim Yap, Min Han Tan, Peter Ang, Ann Siew Gek Lee

24.05.2019 | Epidemiology | Ausgabe 1/2019

The effect of local therapy on breast cancer-specific mortality of women with occult breast cancer and advanced nodal disease (N2/N3): a population analysis

Helen M. Johnson, William Irish, Nasreen A. Vohra, Jan H. Wong

25.05.2019 | Epidemiology | Ausgabe 1/2019

Combined effect of volumetric breast density and body mass index on breast cancer risk

Natalie J. Engmann, Christopher G. Scott, Matthew R. Jensen, Stacey Winham, Diana L. Miglioretti, Lin Ma, Kathleen Brandt, Amir Mahmoudzadeh, Dana H. Whaley, Carrie Hruska, Fang Wu, Aaron D. Norman, Robert A. Hiatt, John Heine, John Shepherd, V. Shane Pankratz, Celine M. Vachon, Karla Kerlikowske

28.05.2019 | Epidemiology | Ausgabe 1/2019

The use of contralateral prophylactic mastectomy among elderly patients in the United States

Schelomo Marmor, Ariella M. Altman, William T. Mayleben, Jane Y. C. Hui, Jason W. Denbo, Eric H. Jensen, Todd M. Tuttle

29.05.2019 | Epidemiology | Ausgabe 1/2019

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

Thomas Helland, Kari Britt Hagen, Martha Eimstad Haugstøyl, Jan Terje Kvaløy, Siri Lunde, Kirsten Lode, Ragna Anne Lind, Birgitta Haga Gripsrud, Kristin Jonsdottir, Jennifer Gjerde, Ersilia Bifulco, Steinar Hustad, Janne Jonassen, Turid Aas, Tone Hoel Lende, Ernst Asbjørn Lien, Emiel Adrianus Maria Janssen, Håvard Søiland, Gunnar Mellgren

30.05.2019 | Epidemiology | Ausgabe 1/2019

Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice

Stephanie Saw, John Lim, Swee Ho Lim, Mabel Wong, Cindy Lim, Yoon Sim Yap

30.05.2019 | Epidemiology | Ausgabe 1/2019

Employment trends in young women following a breast cancer diagnosis

Shoshana M. Rosenberg, Ines Vaz-Luis, Jingyi Gong, Padma Sheila Rajagopal, Kathryn J. Ruddy, Rulla M. Tamimi, Lidia Schapira, Steven Come, Virginia Borges, Janet S. de Moor, Ann H. Partridge

01.06.2019 | Epidemiology | Ausgabe 1/2019

Is immediate breast reconstruction safe in women over 70? An analysis of the National Surgical Quality Improvement Program (NSQIP) database

Fernando A. Angarita, Fahima Dossa, Jesse Zuckerman, David R. McCready, Tulin D. Cil

01.06.2019 | Brief Report | Ausgabe 1/2019

Radiation oncology crossword: breast cancer

Shearwood McClelland III, Ryan M. Rhome, Richard C. Zellars

22.05.2019 | Letter to the Editor | Ausgabe 1/2019

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

Roberta Maltoni, Sara Bravaccini

25.05.2019 | Letter to the Editor | Ausgabe 1/2019

ER(+)/HER2(+) and ER−/HER2(+) breast cancers might have different intracranial recurrence patterns after brain-directed radiation for brain metastases

Kadri Altundag

05.06.2019 | Correction | Ausgabe 1/2019

Correction to: Racial disparities in surveillance mammography among older breast cancer survivors

Jimmitti Teysir, Nana Gegechkori, Juan P. Wisnivesky, Jenny J. Lin

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise